Takeda Pharmaceutical

Takeda Pharmaceutical Company Limited is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan. With a history spanning over 240 years, Takeda is committed to bringing Better Health and a Brighter Future to people worldwide by translating science into life-changing medicines. The company focuses on four therapeutic areas: Oncology, Rare Diseases, Neuroscience, and Gastroenterology, with targeted investments in Plasma-Derived Therapies and Vaccines.

Sustainability at Takeda Pharmaceutical

Takeda is dedicated to sustainability and has integrated Environmental, Social, and Governance (ESG) factors into its business strategy. The company has been recognized for its efforts in sustainability through various awards and certifications. Takeda's sustainability initiatives include:

• Commitment to achieving carbon neutrality by 2040.
• Implementation of energy-efficient practices and renewable energy sources across its operations.
• Active participation in the United Nations Global Compact and alignment with the Sustainable Development Goals (SDGs).
• Publication of annual ESG reports detailing their progress and future goals.
• Recognition by the Dow Jones Sustainability World Index and FTSE4Good Index for their sustainability performance.

For more detailed information on Takeda's sustainability efforts, please refer to their latest ESG report available on their official website.